for your


is a spin off company

 from the Centre for Genomic Regulation (Barcelona - Spain)

founded by experienced entrepreneurs and funded

by invivo Ventures.

 Pulmobiotics will use its technology to discover and develop novel treatments and vaccines for respiratory diseases, which are among the most common causes of severe illness and death worldwide.

 Pulmobiotics       |       Platform       |      Respiratory diseases     |      Partners       |       Team        |     Contact



 A novel live biotherapeutic platform

for treating human lung diseases.

Pioneering live biotherapeutics

in the respiratory tract.


Follow us

Pulmobiotics - All rights reserved © 2020